These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

267 related items for PubMed ID: 1191974

  • 1. Diseases of the central nervous system. Myasthenia gravis.
    Havard CW.
    Br Med J; 1975 Oct 18; 4(5989):152-4. PubMed ID: 1191974
    [No Abstract] [Full Text] [Related]

  • 2. Treatment of myasthenia--I.
    Br Med J; 1971 Apr 17; 2(5754):160-2. PubMed ID: 4325739
    [No Abstract] [Full Text] [Related]

  • 3. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
    Kunze K.
    Med Klin; 1973 Jun 01; 68(22):723-30. PubMed ID: 4715780
    [No Abstract] [Full Text] [Related]

  • 4. Treatment of myasthenia. II.
    Br Med J; 1971 Apr 24; 2(5755):213-4. PubMed ID: 5575956
    [No Abstract] [Full Text] [Related]

  • 5. [On the therapy of muscular diseases].
    Mittelbach F, Bodechtel G.
    Munch Med Wochenschr; 1968 Sep 06; 110(36):1988-93. PubMed ID: 5695705
    [No Abstract] [Full Text] [Related]

  • 6. [Myasthenia gravis].
    Havard CW, Lange MJ.
    Recenti Prog Med; 1977 Jan 06; 62(1):9-26. PubMed ID: 323942
    [No Abstract] [Full Text] [Related]

  • 7. [Current treatment of myasthenia gravis].
    de Assis JL.
    Rev Paul Med; 1965 Oct 06; 67(4):231-42. PubMed ID: 5848156
    [No Abstract] [Full Text] [Related]

  • 8. Myasthenia gravis and glycopyrrolate.
    Marcus E, Wayne F.
    S Afr Med J; 1981 Oct 24; 60(17):650. PubMed ID: 7302713
    [No Abstract] [Full Text] [Related]

  • 9. The Eaton-Lambert syndrome in ocular myasthenia gravis.
    Oh SJ.
    Arch Neurol; 1974 Sep 24; 31(3):183-6. PubMed ID: 4855164
    [No Abstract] [Full Text] [Related]

  • 10. Pharmacologic enhancement of neuromuscular transmission in myasthenia gravis.
    Riggs JE.
    Clin Neuropharmacol; 1982 Sep 24; 5(3):277-92. PubMed ID: 6288236
    [No Abstract] [Full Text] [Related]

  • 11. Progress in myasthenia gravis.
    Havard CW.
    Br Med J; 1973 Aug 25; 3(5877):437-40. PubMed ID: 4353620
    [No Abstract] [Full Text] [Related]

  • 12. Teaching NeuroImages: reversible ectropion in myasthenia gravis.
    Solé G, Perez F, Ferrer X.
    Neurology; 2009 Oct 20; 73(16):e83. PubMed ID: 19841376
    [No Abstract] [Full Text] [Related]

  • 13. [Therapy of pseudoparalytic myasthenia gravis].
    Fasshauer K.
    Dtsch Med Wochenschr; 1975 Oct 31; 100(44):2283-4. PubMed ID: 1183327
    [No Abstract] [Full Text] [Related]

  • 14. Post-varicella myasthenia gravis.
    Saha A, Batra P, Vilhekar KY, Chaturvedi P.
    Singapore Med J; 2007 Jun 31; 48(6):e177-80. PubMed ID: 17538742
    [Abstract] [Full Text] [Related]

  • 15. The interaction of human cholinesterases with anticholinesterases used in the therapy of myasthenia gravis.
    Foldes FF, Smith JC.
    Ann N Y Acad Sci; 1966 Jan 26; 135(1):287-301. PubMed ID: 5221345
    [No Abstract] [Full Text] [Related]

  • 16. Anticholinesterase abuse in myasthenia gravis.
    Munsat TL.
    J Neurol Sci; 1984 Apr 26; 64(1):5-10. PubMed ID: 6376715
    [No Abstract] [Full Text] [Related]

  • 17. The management of myasthenia gravis.
    Drug Ther Bull; 1977 Apr 15; 15(8):29-32. PubMed ID: 872734
    [No Abstract] [Full Text] [Related]

  • 18. Myasthenia gravis, an often overlooked disease in the geriatric group.
    Stern FH.
    J Am Geriatr Soc; 1966 Oct 15; 14(10):1052-7. PubMed ID: 5924629
    [No Abstract] [Full Text] [Related]

  • 19. Current treatment of myasthenia gravis.
    Osterman PO.
    Prog Brain Res; 1990 Oct 15; 84():151-61. PubMed ID: 2267293
    [No Abstract] [Full Text] [Related]

  • 20. [Myasthenia gravis. Immunosuppressive treatment].
    Horn J.
    Tidsskr Nor Laegeforen; 1971 Apr 20; 91(11):821-4. PubMed ID: 4326179
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.